PATIENTVIEW_LIMITED - Accounts


PATIENTVIEW LIMITED
Company Registration No. 03944382 (England and Wales)
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018
PAGES FOR FILING WITH REGISTRAR
PATIENTVIEW LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 6
PATIENTVIEW LIMITED
BALANCE SHEET
AS AT
31 MARCH 2018
31 March 2018
- 1 -
2018
2017
Notes
£
£
£
£
Fixed assets
Tangible assets
3
5,437
5,939
Current assets
Debtors
4
185,119
90,923
Cash at bank and in hand
41
12,620
185,160
103,543
Creditors: amounts falling due within one year
5
(21,721)
(7,085)
Net current assets
163,439
96,458
Total assets less current liabilities
168,876
102,397
Provisions for liabilities
(1,233)
-
Net assets
167,643
102,397
Capital and reserves
Called up share capital
6
12,076
12,076
Share premium account
343,768
343,768
Profit and loss reserves
(188,201)
(253,447)
Total equity
167,643
102,397

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.

PATIENTVIEW LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2018
31 March 2018
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 27 November 2018 and are signed on its behalf by:
Dr A M Wyke
Director
Company Registration No. 03944382
PATIENTVIEW LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018
- 3 -
1
Accounting policies
Company information

PatientView Limited is a private company limited by shares incorporated in England and Wales. The registered office is 1 Fleet Place, London, EC4M 7WS.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.true

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures, fittings & equipment
25% Reducing balance
Computer equipment
33% Reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

PATIENTVIEW LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
1
Accounting policies
(Continued)
- 4 -
1.5
Cash at bank and in hand

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

1.10
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation are included in the profit and loss account for the period.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 3 (2017 - 3).

PATIENTVIEW LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
- 5 -
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2017
23,706
Additions
2,989
Disposals
(10,084)
At 31 March 2018
16,611
Depreciation and impairment
At 1 April 2017
17,767
Depreciation charged in the year
2,442
Eliminated in respect of disposals
(9,035)
At 31 March 2018
11,174
Carrying amount
At 31 March 2018
5,437
At 31 March 2017
5,939
4
Debtors
2018
2017
Amounts falling due within one year:
£
£
Trade debtors
92,500
-
Other debtors
74,137
72,441
166,637
72,441
Amounts falling due after more than one year:
Corporation tax recoverable
18,482
18,482
Total debtors
185,119
90,923
PATIENTVIEW LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
- 6 -
5
Creditors: amounts falling due within one year
2018
2017
£
£
Bank loans and overdrafts
11,944
-
Trade creditors
13,615
-
Other taxation and social security
-
3,432
Other creditors
(3,838)
3,653
21,721
7,085
6
Called up share capital
2018
2017
£
£
Ordinary share capital
Issued and fully paid
12,076 Ordinary of £1 each
12,076
12,076
12,076
12,076
7
Directors' transactions

Advances or credits have been granted by the company to its directors as follows:

Description
% Rate
Opening balance
Interest charged
Amounts repaid
Closing balance
£
£
£
£
Alexandra Wyke
2.50
71,852
1,861
(3,765)
69,948
71,852
1,861
(3,765)
69,948
2018-03-312017-04-01falseCCH SoftwareCCH Accounts Production 2018.220No description of principal activity05 December 2018Mr C J W H NeadDr A M WykeDr A M Wyke2018-11-27039443822017-04-012018-03-31039443822018-03-31039443822017-03-3103944382core:OtherPropertyPlantEquipment2018-03-3103944382core:OtherPropertyPlantEquipment2017-03-3103944382core:CurrentFinancialInstruments2018-03-3103944382core:CurrentFinancialInstruments2017-03-3103944382core:ShareCapital2018-03-3103944382core:ShareCapital2017-03-3103944382core:SharePremium2018-03-3103944382core:SharePremium2017-03-3103944382core:RetainedEarningsAccumulatedLosses2018-03-3103944382core:RetainedEarningsAccumulatedLosses2017-03-3103944382core:ShareCapitalOrdinaryShares2018-03-3103944382core:ShareCapitalOrdinaryShares2017-03-3103944382bus:Director22017-04-012018-03-3103944382core:FurnitureFittings2017-04-012018-03-3103944382core:ComputerEquipment2017-04-012018-03-31039443822016-04-012017-03-3103944382core:OtherPropertyPlantEquipment2017-03-3103944382core:OtherPropertyPlantEquipment2017-04-012018-03-3103944382bus:OrdinaryShareClass12017-04-012018-03-3103944382bus:OrdinaryShareClass12018-03-3103944382bus:Director22017-03-3103944382bus:Director22018-03-3103944382bus:PrivateLimitedCompanyLtd2017-04-012018-03-3103944382bus:FRS1022017-04-012018-03-3103944382bus:AuditExemptWithAccountantsReport2017-04-012018-03-3103944382bus:SmallCompaniesRegimeForAccounts2017-04-012018-03-3103944382bus:Director12017-04-012018-03-3103944382bus:CompanySecretary12017-04-012018-03-3103944382bus:FullAccounts2017-04-012018-03-31xbrli:purexbrli:sharesiso4217:GBP